NORMAL SITUATION

DEPHARM

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

-2,2 k €

-105.2% YoY

Gross margin

-1,4 k €

-103.4% YoY

Equity

244,2 k €

-0.9% YoY

Company — Normal situation.

What does DEPHARM do?

DEPHARM is a company registered in Belgium.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0450.345.264

Legal form

Private limited company

Contributed capital

42 141,90 €

Latest accounts

31/12/2024

Joint committees (1)

Signals

Solid equityGood liquidity

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	-1,4 k €	-103%	41,9 k €	+317%	-19,3 k €	-131%	62,7 k €	-42.8%	109,8 k €	-13.7%	127,2 k €	+32.3%	96,2 k €	-11.8%	109,1 k €	-12.3%	124,4 k €	+15.5%	107,7 k €	-24.2%	142 k €	+24.1%	114,4 k €	+30.9%	87,4 k €	+5.6%	82,8 k €	-4.1%	86,3 k €	-2.1%	88,1 k €	-14.5%	103,1 k €	+43.6%	71,8 k €	-18.3%	87,8 k €
EBITDA	-1,8 k €	-104%	42 k €	+157%	-73,7 k €	-274%	-19,7 k €	-212%	17,6 k €	-51.2%	36,1 k €	+98.9%	18,2 k €	-25.5%	24,4 k €	-41.2%	41,5 k €	+71.3%	24,2 k €	-65.7%	70,7 k €	+108%	34 k €	+79.4%	19 k €	+21.8%	15,6 k €	+257%	-9,9 k €	-122%	44,1 k €	-33.9%	66,8 k €	+80.1%	37,1 k €	-30.1%	53,1 k €
Operating result	-1,8 k €	-104%	42 k €	+157%	-73,7 k €	-224%	-22,7 k €	-251%	15 k €	-55.2%	33,5 k €	+125%	14,9 k €	-21.2%	18,9 k €	-46.6%	35,4 k €	+93.7%	18,3 k €	-72.1%	65,5 k €	+123%	29,3 k €	+122%	13,2 k €	+1.6%	13 k €	+197%	-13,4 k €	-143%	31,4 k €	-48.9%	61,4 k €	+188%	21,3 k €	-40.1%	35,6 k €
Net result	-2,2 k €	-105%	41,7 k €	+214%	-36,5 k €	-73.8%	-21 k €	-176%	27,6 k €	-18.9%	34 k €	+49.7%	22,7 k €	-11.9%	25,8 k €	-18.1%	31,5 k €	+42.4%	22,1 k €	-48.7%	43,1 k €	+100%	21,5 k €	+152%	8,5 k €	+34.7%	6,3 k €	+123%	-27,6 k €	-341%	11,4 k €	-4.5%	12 k €	+492%	-3,1 k €	-126%	11,6 k €
Balance sheet
Equity	244,2 k €	-0.9%	246,4 k €	+20.4%	204,7 k €	-15.1%	241,2 k €	-8.0%	262,2 k €	+11.8%	234,6 k €	-3.7%	243,6 k €	+10.3%	220,8 k €	+13.2%	195 k €	+19.3%	163,5 k €	+15.6%	141,4 k €	+43.9%	98,3 k €	+28.1%	76,7 k €	+12.5%	68,2 k €	+10.3%	61,8 k €	-30.9%	89,4 k €	+14.7%	78 k €	+18.2%	66 k €	-4.4%	69,1 k €
Total assets	261,5 k €	+0.4%	260,6 k €	+17.8%	221,1 k €	-46.4%	412,9 k €	-21.5%	526,3 k €	+0.3%	524,9 k €	+6.3%	493,7 k €	-0.1%	494,4 k €	+5.6%	468,3 k €	-7.6%	506,9 k €	+33.9%	378,5 k €	+17.1%	323,4 k €	-8.0%	351,5 k €	-13.3%	405,4 k €	+7.8%	376,2 k €	-17.1%	453,8 k €	-0.9%	457,8 k €	-17.7%	556,1 k €	+5.1%	529,1 k €
Cash	261,2 k €	+4.8%	249,1 k €	+44.6%	172,3 k €	-29.7%	245 k €	+285%	63,6 k €	+59.0%	40 k €	-12.2%	45,6 k €	-50.2%	91,5 k €	+32.7%	69 k €	+82.7%	37,8 k €	+73.4%	21,8 k €	-50.0%	43,6 k €	-48.6%	84,7 k €	+47.9%	57,3 k €	-20.6%	72,1 k €	-28.8%	101,2 k €	-24.7%	134,3 k €	+375%	28,3 k €	+152%	11,2 k €
Debts	17,3 k €	+22.3%	14,2 k €	-13.6%	16,4 k €	-90.5%	171,7 k €	-35.0%	264,1 k €	-9.0%	290,3 k €	+16.1%	250,2 k €	-8.6%	273,6 k €	+0.1%	273,3 k €	-20.4%	343,4 k €	+44.8%	237,1 k €	+5.3%	225,1 k €	-18.0%	274,5 k €	-18.6%	337,3 k €	+7.3%	314,4 k €	-13.7%	364,4 k €	-4.1%	379,8 k €	-22.1%	487,4 k €	+6.0%	459,9 k €
Other
Workforce	–		–		–		2,5 ETP	+25.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	-16.7%	2,4 ETP	0.0%	2,4 ETP	0.0%	2,4 ETP	0.0%	2,4 ETP	+50.0%	1,6 ETP	+6.7%	1,5 ETP	0.0%	1,5 ETP	+7.1%	1,4 ETP

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 4 ended

Active mandates

GESTIPHARMA

Director · since 27 septembre 2023 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Active

Ended mandates

GESTIPHARMA

Director · since 01 juin 2021 · 0425.530.684

Represented by Pierre HECQ

Ended

Myriam DEMARBE

Director · since 28 juin 1993 · until 13 août 2021

Ended

Myriam DEMARBE

Director · since 28 juin 1993

Ended

Myriam DEMARBE

Manager

Ended

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Micro model	Micro model	Micro model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/07/2025	06/08/2024	22/08/2023	23/08/2022	31/08/2021	30/09/2020
General meeting	01/06/2025	01/06/2024	01/06/2023	18/08/2022	20/08/2021	31/08/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

31 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2024	01/06/2025	14/07/2025	French	PDF
Micro model	31/12/2023	01/06/2024	06/08/2024	French	PDF
Micro model	31/12/2022	01/06/2023	22/08/2023	French	PDF
Abridged model	31/12/2021	18/08/2022	23/08/2022	French	PDF
Abridged model	31/12/2020	20/08/2021	31/08/2021	French	PDF
Abridged model	31/12/2019	31/08/2020	30/09/2020	French	PDF
Abridged model	31/12/2018	31/07/2019	30/09/2019	French	PDF
Abridged model	31/12/2017	31/07/2018	31/08/2018	French	PDF
Abridged model	31/12/2016	31/07/2017	29/08/2017	French	PDF
Abridged model	31/12/2015	15/09/2016	28/09/2016	French	PDF
Abridged model	31/12/2014	10/12/2015	23/12/2015	French	PDF
Abridged model	31/12/2013	30/06/2014	01/12/2014	French	PDF
Abridged model	31/12/2012	30/06/2013	21/11/2013	French	PDF
Abridged model	31/12/2011	30/06/2012	22/10/2012	French	PDF
Abridged model	31/12/2010	30/06/2011	26/08/2011	French	PDF
Abridged model	31/12/2009	30/06/2010	30/09/2010	French	PDF
Abridged model	31/12/2008	30/06/2009	26/04/2010	French	PDF
Abridged model	31/12/2007	30/06/2008	29/09/2008	French	PDF
Abridged model	31/12/2006	01/05/2008	03/06/2008	French	PDF
Abridged model	31/12/2005	15/01/2007	02/02/2007	French	PDF
Abridged model	31/12/2004	30/06/2005	09/06/2006	French	PDF
Abridged model	31/12/2003	30/06/2004	28/04/2005	French	PDF
Abridged model	31/12/2002	27/06/2003	06/05/2004	French	PDF
Abridged model	31/12/2001	28/06/2002	28/03/2003	French	PDF

View all 31 filings

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 4 ended

Active mandates

GESTIPHARMA

Director · since 27 septembre 2023 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Active

Ended mandates

GESTIPHARMA

Director · since 01 juin 2021 · 0425.530.684

Represented by Pierre HECQ

Ended

Myriam DEMARBE

Director · since 28 juin 1993 · until 13 août 2021

Ended

Myriam DEMARBE

Director · since 28 juin 1993

Ended

Myriam DEMARBE

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024-2,2 k €↓
2023
Annual accounts 202341,7 k €↑
2022
Annual accounts 2022-36,5 k €↓
2021
Annual accounts 2021-21 k €↓
2020
Annual accounts 202027,6 k €↓
2019
Annual accounts 201934 k €↑
2018
Annual accounts 201822,7 k €↓
2017
Annual accounts 201725,8 k €↓
2016
Annual accounts 201631,5 k €↑
2015
Annual accounts 201522,1 k €↓
2014
Annual accounts 201443,1 k €↑
2013
Annual accounts 201321,5 k €↑
2012
Annual accounts 20128,5 k €↑
2011
Annual accounts 20116,3 k €↑
2010
Annual accounts 2010-27,6 k €↓
2009
Annual accounts 200911,4 k €↓
2008
Annual accounts 200812 k €↑
2007
Annual accounts 2007-3,1 k €↓
2006
Annual accounts 200611,6 k €

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

DEPHARM

Overview

What does DEPHARM do?

Trend over 19 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Similar companies

Similar companies

Timeline